MAP3K7 loss is sufficient for initiating precancerous and cancerous lesions in tissue recombination mouse models, is associated with high-grade PCa, and is linked to biochemical recurrence and prostatic brain metastases [42,43,44,45,46]. This evidence concerns the gene MAP3K7 and posterior cortical atrophy.